ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Montana » Internal Medicine

Top Internal Medicine Prescribers in Montana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SARAH ROBINSON MD

Internal Medicine

4,856

$284K

289
248 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $54

MICHAEL SPINELLI M.D.

Internal Medicine

4,786

$271K

377
336 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $54

LAURA CSAPLAR MD

Internal Medicine

4,613

$238K

286
241 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $54

THOMAS CAUGHLAN MD

Internal Medicine

4,478

$240K

375
324 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $54

SCOTT SEARS M.D.

Internal Medicine

4,225

$221K

273
249 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $54

CHARLOTTA EATON M.D.

Internal Medicine

4,003

$198K

211
190 are 65+

18%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $54

KAREN IZBICKI PA-C

Internal Medicine

3,963

$210K

341
307 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $54

ERICA BRUEN M.D.

Internal Medicine

3,863

$255K

237
191 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$66
Average prescription price

Avg: $54

LISA MILCH M.D.

Internal Medicine

3,853

$162K

159
138 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

26%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $54

KELLY REDFIELD M.D.

Internal Medicine

3,695

$177K

197
175 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $54

JAMES HEYBOER MD

Internal Medicine

3,661

$170K

272
214 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $54

JOE GREGORY DO

Internal Medicine

3,648

$215K

441
314 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $54

TERESA BALDRIDGE MD

Internal Medicine

3,437

$142K

272
215 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$41
Average prescription price

Avg: $54

JEAN JUSTAD MD

Internal Medicine

3,195

$192K

114
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $54

DOUGLAS SWIFT MD

Internal Medicine

3,110

$149K

236
224 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $54

DAVID CRITES MD

Internal Medicine

2,981

$163K

252
186 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $54

STEFFAN MAY M.D.

Internal Medicine

2,703

$143K

174
133 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $54

JANELLE DONOVAN MD

Internal Medicine

2,586

$136K

228
208 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $54

THOMAS KELLY MD

Internal Medicine

2,533

$160K

196
161 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $54

VICTORIA WANG M.D.

Internal Medicine

2,406

$135K

77
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $54

BRYAN WEBB MD

Internal Medicine

2,387

$68.4K

318
255 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$29
Average prescription price

Avg: $54

MECHELLE LEWIS M.D.

Internal Medicine

2,303

$104K

178
140 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $54

HUGH HUGHSON MD

Internal Medicine

2,102

$134K

215
203 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$64
Average prescription price

Avg: $54

ARTHUR FINK D.O.

Internal Medicine

2,038

$89.3K

132
114 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $54

MARK GOBIN DO

Internal Medicine

2,012

$128K

245
190 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$64
Average prescription price

Avg: $54

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank